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Abstract
Exposure to the major air pollutant ozone can aggravate asthma and other lung diseases. Our
recent study in human volunteers has shown that the glutathione S-transferase mu 1 (GSTM1) null
genotype is associated with increased airway neutrophilic inflammation induced by inhaled ozone.
The aim of this study was to examine the effect of GSTM1 modulation on interleukin 8 (IL-8)
production in ozone-exposed human bronchial epithelial cells (BEAS-2B) and the underlying
mechanisms. Exposure of BEAS-2B cells to 0.4 ppm ozone for 4 h significantly increased IL-8
release with a modest reduction in intracellular reduced glutathione (GSH). Ozone exposure
induced reactive oxygen species (ROS) production and NFκB activation. Pharmacological
inhibition of NFκB activation or mutation of IL-8 promoter at κB-binding site significantly
blocked ozone-induced IL-8 production or IL-8 transcriptional activity, respectively. Knockdown
of GSTM1 in BEAS-2B cells enhanced ozone-induced NFκB activation and IL-8 production.
Consistently, ozone-induced overt increase in IL-8 production was detected in GSTM1-null
primary human bronchial epithelial cells. In addition, supplementation with reduced GSH
inhibited ozone-induced ROS production, NFκB activation and IL-8 production. Taken together,
GSTM1 deficiency enhances ozone-induced IL-8 production, which is mediated by generated ROS
and subsequent NFκB activation in human bronchial epithelial cells.
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Introduction
Ozone is one of the most abundant components of air pollution in urban areas and is thought
to act, in part, as an inducer of airway inflammation (1–4). This agent is generated at ground
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level by photochemical reactions involving nitrogen dioxide, oxygen, hydrocarbons, and
ultraviolet (UV) radiation. Human activities are major sources of ozone precursors, although
the latter are also generated by nonanthropogenic processes (5). Increased outdoor levels of
ozone have been associated with an increased risk of admissions for asthma, chronic
obstructive pulmonary disease and increased mortality in patients with asthma and the
general population (6–10). Controlled inhalation studies of both asthmatic and non-
asthmatic adults have revealed an acute decrease in lung function, enhanced allergen-
induced bronchoconstriction and increases in airway inflammation typified by increased
influx of neutrophils after ozone challenge (11–16). However, the mechanisms underlying
ozone-induced airway inflammation have not been fully elucidated.
Airway inflammation is a central feature of many respiratory diseases. The specific
characteristics of the inflammatory response in each disease and the site of inflammation
differ but all involve the recruitment and activation of inflammatory cells and changes in the
structural cells of the lung. These conditions are characterized by an increased expression of
the inflammatory mediators including cytokines, chemokines, growth factors, enzymes,
receptors and adhesion molecules (17). The airway epithelium represents the interface
between the external environment and tissue of the airway wall. The production of pro-
inflammatory mediators from airway epithelial cells exposed to environmental irritants plays
a critical role in the pathogenesis of airway disorders, such as asthma (18). Among these
pro-inflammatory mediators, interleukin 8 (IL-8) is a potent neutrophil activator and
chemotaxin and often used as a biological marker of environmentally induced pulmonary
inflammation (19–21). Ozone inhalation induces human airway epithelial damage and
increased release of pro-inflammatory mediators including IL-8 in bronchoalveolar lavage
fluids (BALF) (22, 23). In vitro exposure of human bronchial epithelial cells to ozone
increases IL-8 production (24–26). In this study, we used IL-8 as the biomarker of ozone-
induced airway inflammation and explored the regulatory events in ozone-induced IL-8
expression in human bronchial epithelial cells.
The toxicological effects of ozone are affected by many factors. In addition to the
concentration and duration of exposure and co-existence of other air pollutants (4, 27–29),
host susceptibility factors play a key role in determining the risk for ozone-induced airway
inflammation. Ozone is a strong pro-oxidant and reacts with the epithelial lining fluid to
generate free radicals (30). Genetic association studies of ozone exposure in humans have
revealed an association between polymorphisms in oxidative stress genes such as
glutathione-S-transferase M1 (GSTM1), and exacerbation of asthma (31). Asthmatic
children with GSTM1 null and GSTP1 valine/valine genotypes appear more susceptible to
developing respiratory symptoms related to ozone exposure (32). Furthermore, a clinical
trial showed that children with asthma with the low antioxidant GSTM1 genotype had a fall
in lung function with increasing ozone concentration, unless protected by antioxidant
supplementation with vitamins C and E (33). We recently reported that GSTM1 null
volunteers had significantly increased airway neutrophils after ozone challenge compared to
GSTM1 sufficient volunteers, although nociceptive decreases in pulmonary function was
similar between these groups (34). It should be noted that these in vivo studies only
investigated the association of GSTM1 genotype with pollutant-induced lung inflammation,
and they cannot exclude contribution of other genetic factors in modulation of response to
ozone. To our knowledge, no mechanistic studies have been conducted to examine the
function of GSTM1 protein in the pathogenesis of airway inflammation. Given the key role
IL-8 plays in neutrophil chemotaxis, this study specifically examined the effect of deficient
GSTM1 protein expression on ozone-induced IL-8 expression in human bronchial epithelial
cells.
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Triton X-100, polyacrylamide and glutathione ethyl ester (GSH-ET) were purchased from
Sigma Chemical Co. (St. Louis, MO). SDS-PAGE supplies such as molecular mass
standards and buffers were from Bio-Rad (Richmond, CA). 5-(and-6)-carboxy-2′, 7′-
dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) was purchased from Invitrogen
Corporation (Carlsbad, CA). Bay11-7082 was obtained from EMD Chemicals Inc.
(Gibbstown, NJ). IκBα antibody and horseradish peroxidase (HRP)-conjugated goat anti-
rabbit antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). βactin
antibody was purchased from USBiological (Swampscott, MA). Lactate dehydrogenase
(LDH) cytotoxicity detection kit was obtained from TAKARA Bio Inc. (Mountain View,
CA). QuantiChromTM GSH assay kit was obtained from BioAssay Systems (Hayward, CA).
Rabbit anti-human GSTM1 antibody and GST activity assay kit was purchased from
Cayman Chemical Company (Ann Arbor, MI). IL-8 ELISA assay kit was purchased from
eBioscience (San Diego, CA). Chemiluminescence reagents, expression arrest GIPZ
lentiviral GSTM1 shRNA particles and non-silencing control shRNA particles were obtained
from Thermo Scientific (Huntsville, AL).
Cell culture and ozone exposure
BEAS-2B cell line: The BEAS-2B cell line was derived by transforming human bronchial
epithelial cells with an adenovirus 12-simian virus 40 construct (35, 36). BEAS-2B cells
(passages 70–80) were cultured in keratinocyte basal medium (KBM) supplemented with 30
μg/ml bovine pituitary extract, 5 ng/ml human epidermal growth factor (EGF), 500 ng/ml
hydrocortisone, 0.1 mM ethanolamine, 0.1 mM phosphoethanolamine, and 5 ng/ml insulin
(keratinocyte growth medium, KGM). 3×105 BEAS-2B cells were placed on collagen-
coated filter supports (transwell insert) with a 0.4 μm pore size (Costar, Cambridge, MA)
and grown overnight. The culture medium on the apical side of the transwell was removed
immediately before BEAS-2B cells were exposed to sterile air or 0.4 ppm ozone for 4 h in
the exposure chambers operated by the US Environmental Protection Agency
Environmental Public Health Division.
Normal human bronchial epithelial (NHBE) cells were obtained from normal adult human
volunteers with the GSTM1-null or sufficient genotype by brush biopsy of the mainstem
bronchus using a cytology brush during fiberoptic bronchoscopy, conducted under a
protocol approved by the Committee on the Protection of the Rights of Human Subjects at
the University of North Carolina at Chapel Hill. NHBE cells were initially plated in
supplemented bronchial epithelial cell basal medium (0.5 ng/ml human EGF, 0.5 μg/ml
hydrocortisone, 5 μg/ml insulin, 10 μg/ml transferrin, 0.5 μg/ml epinephrine, 6.5 ng/ml
triiodothyronine, 50 μg/ml gentamycin, 50 ng/ml amphotericin-B, 52 μg/ml bovine pituitary
extract and 0.1 ng/ml retinoic acid) on tissue culture flasks. Confluent cells were split and
placed on the transwell before ozone exposure.
Measurement of intracellular reduced GSH
BEAS-2B cells were exposed to 0.4 ppm ozone for 4 h. The cells were scraped off the
transwell and lysed by sonication in the cold buffer containing 50 mM MEP (pH=7) and 1
mM EDTA. The cell lysates were centrifuged at 10,000g for 15 min at 4°C. The
supernatants were subjected to intracellular GSH measurement following the manufacturer’s
instruction.
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Measurement of LDH levels in culture medium
BEAS-2B cells were exposed to 0.4 ppm ozone for 4 h. The cell culture medium from the
basolateral chamber of air-liquid interface culture system was collected for the measurement
of LDH concentration according to the manufacturer’s instruction. Released LDH content
was expressed as optical density (OD).
Enzyme linked immunosorbent assay (ELISA)
After exposure of BEAS-2B cells to 0.4 ppm ozone for 4 h, the culture medium from the
basolateral compartment of the transwell unit was collected and centrifuged. Levels of IL-8
protein in the supernatants were measured with a human IL-8 ELISA kit following the
manufacturer's instructions.
Immunoblotting
BEAS-2B cells exposed to sterile air or ozone were washed twice with ice-cold phosphate-
buffered saline (PBS), and then lysed in RIPA buffer (1× PBS, 1% nonidet P-40, 0.5%
sodium deoxycholate, 0.1% SDS, and protease inhibitors: 20 μg/ml leupeptin, 20 μg/ml
aprotinin, 0.5 mM phenylmethylsulfonyl fluoride, 200 μM sodium orthovanadate, and 20
mM sodium fluoride). The supernatants of cell lysates were subjected to SDS-PAGE.
Proteins were transferred onto nitrocellulose membrane. Membrane was blocked with 5%
nonfat milk, washed briefly, incubated with primary antibody at 4°C overnight, followed by
incubating with corresponding HRP-conjugated secondary antibody for 1 h at room
temperature. Immunoblot images were detected using chemiluminescence reagents and the
Fujifilm LAS-3000 imaging system (Fuji Medical Systems, USA).
GSTM1 knockdown assay
5×104 BEAS-2B cells were placed in a 12 well plate and grown overnight. 10 moi
(multiplicity of infection) of lentiviral non-silencing (scrambled) or GSTM1 shRNA
particles in 0.5 ml KBM were incubated with BEAS-2B cells for 6 h. Then 0.5 ml KGM was
added into the infection medium and incubated for another 18 h. Confluent BEAS-2B cells
were lysed and assayed for GSTM1 protein levels using immunoblotting.
Real-time reverse transcriptase/polymerase chain reaction (RT-PCR)
BEAS-2B cells expressing wild-type or mutated (κB-binding site) IL-8 promoter-conjugated
firefly luciferase (fLCF) construct, and enhanced green fluorescent protein (EGFP)
construct (37) were exposed to sterile air or 0.4 ppm ozone for 4 h, respectively. The cells
were lysed with TRIZOL reagent (Invitrogen Corporation, Carlsbad, CA). Total RNA (100
ng), 0.5 mM NTP (Pharmacia, Piscataway, NJ), 5 μM random hexaoligonucleotide primers
(Pharmacia, NJ), 10 U/μl RNase inhibitor (Promega, CA), and 10 U/μl Moloney murine
leukemia virus RT (GIBCO-BRL Life Technologies) were incubated in a 40°C water bath
for 1 h in 50 μl of 1× PCR buffer to synthesize first-strand cDNAs. The reverse transcription
was inactivated by heating at 92°C for 5 min. Oligonucleotide primer pairs and fluorescent
probes for fLCF and EGFP were designed and obtained from Integrated DNA Technologies
(Coralville, IA). Quantitative fluorogenic amplification of cDNA was performed using the
ABI Prism 7500 Sequence Detection System (Perkin-Elmer, CA). The relative abundance of
fLCF mRNA levels was calculated using the difference between the cycle threshold (CT) of
the fLCF mRNA sequence and the reference EGFP mRNA sequence.
Measurement of intracellular reactive oxygen species (ROS)
The intracellular formation of ROS in BEAS-2B cells was detected using the fluorescent
ROS probe carboxy-H2DCFDA. Carboxy-H2DCFDA is a cell-permeant indicator for ROS
that is nonfluorescent until the acetate groups are removed by intracellular esterases and
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oxidation occurs within the cell (38). The green fluorescence produced by BEAS-2B cells is
proportional to the amount of ROS produced. Briefly, confluent BEAS-2B cells were pre-
incubated with 20 μM carboxy-H2DCFDA at 37 °C for 1 h prior to exposure to 0.4 ppm
ozone for 4 h. Cells were detached by 0.05% trypsin-EDTA, washed once with PBS,
suspended in 0.5 ml PBS and put on ice before determination of green fluorescence
intensity. Flow cytometry was performed with a FACSORT (Becton–Dickinson, Miami, FL,
USA) by using an argon-ion laser (wavelength 488 nm). The FACSORT was calibrated with
Calibrite beads before each use, and 6000 events were counted for all sample runs. Relative
cell size and density/granularity were quantified by analyzing light-scatter properties using
CellQuest software (Becton–Dickinson), namely forward scatter for cell size and side scatter
for density/granularity, and recording the mean fluorescence intensities for each.
GSTM1 activity assay
NHBE cells from human volunteers with the GSTM1-null or -sufficient genotype were
suspended into the sample buffer (100 mM potassium phosphatases, pH6.5, containing 0.1%
Triton X-100 and 1 mM glutathione). The cells were broken down with sonication and the
supernatants subjected to immuoprecipitation. Specifically, 5 μl of rabbit anti-human
GSTM1 antibody was incubated with the supernatant at 4°C for 2 h prior to addition of 10 μl
Protein A-agarose and incubated at 4°C overnight. The immunoprecitates were washed with
cold PBS three times before determination of GST activity following the manufacturer’s
instructions.
Statistical analysis
Data were presented as means ± SE and evaluated using nonparametric paired t tests with
the overall α level set at 0.05.
Results
Ozone exposure induces increased IL-8 production as well as cell damage to human
bronchial epithelial cells
The overproduction of IL-8 is a biomarker of airway inflammation (39, 40). In vivo and in
vitro studies have shown that ozone exposure elevates IL-8 protein levels in BALF or
culture medium (22–26). Since ozone effect is concentration- and time-dependent, and cell
type-specific (41), we examined IL-8 production in BEAS-2B cells exposed to 0.4 ppm
ozone for 4 h referred to our recent in vivo study (16). Levels of IL-8 protein in the
supernatant of culture medium were determined using ELISA. As shown in Figure 1A,
ozone exposure significantly increased IL-8 protein release from BEAS-2B cells as
compared to control (sterile air). As expected, the positive control IL-1β (10 ng/ml) induced
a pronounced increase in IL-8 production from BEAS-2B cells (Figure 1A).
Under the same exposure condition, the cytotoxicity of ozone exposure was assessed by
assay of LDH activity in the culture medium. It was shown that ozone stimulation
significantly elevated LDH levels in the culture medium of BEAS-2B cells compared to air
(Figure 1B). This result indicated that exposure to 0.4 ppm ozone for 4 h could cause cell
injury, which was consistent with previous observation (42).
Ozone exposure induces ROS production that can be inhibited by supplementation of
reduced GSH
Ozone is a highly reactive gas associated with oxidative stress (43). ROS production has
been shown in ozone-exposed guinea pig airway epithelial cells and human BALF cells (44,
45). To examine whether ozone challenge increased ROS production in BEAS-2B cells, the
fluorogenic probe carboxy-H2DCFDA was used. As demonstrated in Figure 2A, exposure of
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BEAS-2B cells to 0.4 ppm ozone for 4 h resulted in increased ROS production in BEAS-2B
cells. To determine whether ROS production could be inhibited by antioxidant, we next
employed the reduced GSH (GSH-ET) to pretreat BEAS-2B cells prior to ozone exposure.
As shown in Figure 2B, pre-incubation of BEAS-2B cells with 10 mM GSH-ET for 1 h
modestly inhibited ozone-induced ROS production, indicating that reduced GSH is an
antagonist of ROS induced by ozone stimulation.
Ozone-induced reduction of intracellular reduced GSH and its association with IL-8
production
The fact that supplementation of reduced GSH inhibited ozone-induced ROS production
implied that ozone exposure might affect intracellular reduced GSH levels. To test this
assumption, the intracellular reduced GSH levels were measured after ozone treatment (0.4
ppm ozone for 4 h). As shown in Figure 3A, ozone exposure induced a modest reduction in
intracellular reduced GSH levels. To further examine the association of intracellular GSH
with ozone-induced IL-8 expression, BEAS-2B cells were pre-incubated with 10 mM GSH-
ET for 1 h before exposure to ozone. The medium containing GSH-ET on the apical side of
the transwell was removed just before ozone exposure, but the GSH-ET remained in the
basolateral culture medium. Levels of IL-8 protein in the culture supernatant of basolateral
medium were measured as described previously. As expected, in the vehicle group ozone
exposure increased IL-8 production (Figure 3B). In contrast, GSH-ET pretreatment
markedly inhibited ozone-induced IL-8 release from BEAS-2B cells. These results
suggested that reduction of intracellular reduced GSH could result in ozone-induced IL-8
production.
In addition, GSH-ET supplementation was also shown to inhibit ozone-induced cell toxicity
(Data not shown).
GSTM1 knockdown enhances ozone-induced IL-8 production
GSTM1 has been detected in the brush border of proximal airways as well as in alveolar
cells and macrophages (46). Our recent in vivo study has revealed that GSTM1 null genotype
is associated with increased neutrophilic airway inflammation after ozone exposure (34).
Since IL-8 is a potent neutrophil chemokine we hypothesized that GSTM1 homeostasis is
associated with the expression levels of IL-8 in ozone-treated human bronchial epithelial
cells. To examine this hypothesis, we modulated intracellular GSTM1 levels in BEAS-2B
cells with lentiviral GSTM1 shRNA particles and then compared the difference in IL-8
production from BEAS-2B cells expressing adequate or deficient GSTM1 after ozone
challenge. Infection of BEAS-2B cells with 10 moi of lentiviral GSTM1 shRNA particles
caused significant reduction of GSTM1 protein levels (by 82%) in BEAS-2B cells as
compared to the cells infected with scrambled lentiviral shRNA particles (Figure 4A).
GSTM1 adequate or deficient (knockdown) cells were further treated with air or 0.4 ppm
ozone for 4 h and IL-8 levels in the culture supernatants measured. In the cells expressing
scrambled shRNA ozone stimulation increased IL-8 production from BEAS-2B cells (Figure
4B). In the cells expressing GSTM1 shRNA ozone-induced IL-8 production was further
increased by GSTM1 knockdown (Figure 4B).
To further verify the observation in BEAS-2B cells, we next used normal human bronchial
epithelial cells from volunteers with the GSTM1-null or -sufficient genotype to determine
the association of GSTM1 with IL-8 production after ozone exposure. GSTM1 activity was
first examined in the NHBE cells with the GSTM1-null or sufficient genotype using
immunoprecipitation. As expected, GSTM1 activity was not detected in GSTM1-null NHBE
cells. In contrast, GSTM1 enzymatic activity was detected in GSTM1-sufficient NHBE cells
(Figure 4C). Furthermore, Ozone exposure (0.4 ppm, 4 h) induced a significant increase in
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IL-8 production from the cells with GSTM1-null genotype than that from the GSTM1-
sufficient bronchial epithelial cells (Figure 4D). As shown in BEAS-2B cells, IL-1β (10 ng/
ml) significantly increased IL-8 production from normal human bronchial epithelial cells
(data not shown).
NFκB activation is required for ozone-induced IL-8 production
Activation of the transcription factor NFκB is required for IL-8 gene transcription in many
cell types (47). To examine whether ozone stimulation activated NFκB, degradation of the
NFκB inhibitory protein κBα (IκBα), an event indicative of the canonical NFκB-activating
pathway (48), was determined. BEAS-2B cells were exposed to 0.4 ppm ozone for 30 and
60 min. IκBα levels in the cell lysates were measured using immunoblotting. As shown in
Figure 5A, exposure of BEAS-2B cells to ozone for 30 min had minimal effect on IκBα
levels. However, at 60 min exposure to ozone, the IκBα levels dropped significantly in
compared to those of control, indicating that ozone exposure could activate NFκB at 60 min
exposure. To further examine whether NFκB was involved in ozone-induced IL-8
production, Bay11-7082, a specific and potent inhibitor of NFκB activation that inhibits the
phosphorylation and degradation of IκBα and subsequent nuclear translocation of p65 and
p50 (49), was used prior to ozone treatment. BEAS-2B cells were pre-incubated with 20 μM
Bay11-7082 for 60 min before further challenged with 0.4 ppm ozone for 4 h. As shown in
Figure 5B, Bay11-7082 pretreatment abolished ozone-induced IL-8 production, implying
that NFκB was required for ozone-induced IL-8 production. To support this notion,
BEAS-2B cells expressing wild-type or mutated (κB-binding site) IL-8 promoter-conjugated
fLCF, and EGFP constructs were employed. Levels of fLCF mRNA are proportional to the
transcriptional activities of IL-8 promoter. As demonstrated in Figure 5C, ozone exposure
increased fLCF mRNA levels in the cells encoding wild-type IL-8 promoter (IL-8wt).
However, this effect of ozone exposure was significantly reduced in the cells containing
mutated (κB-binding site) IL-8 promoter (IL-8mNFκB). Taken together, these results
indicate that ozone exposure activates NFκB, which is required for ozone-induced IL-8 gene
expression in human bronchial epithelial cells.
GSTM1 modulate ozone-induced NFκB activation
As demonstrated previously, both GSTM1 and NFκB were involved in the regulation of
ozone-induced IL-8 production from BEAS-2B cells. We next examined the possible
association of GSTM1 with NFκB in ozone-induced IL-8 production. BEAS-2B cells were
infected with lentiviral scrambled or GSTM1 shRNA particles, respectively, as described
previously. As shown in Figure 6A, in the cells expressing scrambled shRNA, ozone
exposure induced marked IκBα degradation. In contrast, in the cells encoding GSTM1
shRNA the IκBα levels went even lower than those in the cells containing scrambled shRNA
after ozone exposure, which indicated that GSTM1 knockdown enhanced ozone-induced
NFκB activation. Consistent with this observation, the antioxidant GSH-ET supplementation
significantly inhibited ozone-induced IκBα degradation (NFκB activation) in BEAS-2B cells
(Figure 6B).
Discussion
GSTM1 belongs to a family of dimeric phase II metabolic enzymes known to catalyze the
conjugation of reduced GSH with electrophilic compounds such as products of oxidative
stress (50). GSTM1 has been mapped to the GST mu gene cluster on chromosome 1p13.3.
Deletion variants or null alleles exist for the GSTM1 gene present biochemically as a failure
to express protein (51–55). The GSTM null genotype has been associated with increased risk
for adverse health effects due to exposure to air pollutants (56, 57). Our recent study showed
that the GSTM1 null genotype was associated with increased airway inflammation after
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ozone exposure (34). Consistent with this observation, we now report that silencing of
GSTM1 with shRNA for GSTM1 in human bronchial epithelial cell line or GSTM1-null
genotype of normal human bronchial epithelial cells is associated with ozone-induced
overproduction of IL-8. It should be noted that the methodology used in this study is limited
due to the usage of transformed epithelial cells incubated without the protection of
respiratory tract lining fluids and in artificial culture media.
The results from this study indicate that GSTM1 modulation of IL-8 production from ozone-
treated BEAS-2B cells involves NFκB and ROS. We found that silencing of GSTM1
enhances ozone-induced NFκB activation, which can be inhibited by supplementation with
reduced GSH, the substrate of GSTM1, demonstrating that GSTM1 modulates NFκB
activation. NFκB is a family of highly regulated dimeric transcription factors that play
pivotal roles in inflammatory responses and immunological reactions. Five members of the
NFκB family have been identified: NFκB1 (p50/p105), NFκB2 (p52/p100), RelA (p65),
RelB, and c-Rel (58). In mammals, the NFκB transcription factor consists of two subunits of
either homo- or heterodimers of RelA/p65, c-Rel, and p50. The p50/RelA(p65) heterodimer
is the major Rel/NFκB complex in most cell types (59). NFκB can be activated through two
pathways, the classical (canonical) and alternative pathways. In the classic pathway,
activated IκB kinase β (IKKβ) phosphorylates IκBα, IκBβ, or IκBε, leading to their
proteasomal degradation. As a result, NFκB homodimers and heterodimers accumulate in
the nucleus and regulate the expression of its target genes such as those coding for
cytokines, adhesion molecules and chemokines that have a crucial role in both immune and
inflammatory responses (60–62). The alternative NFκB pathway is responsible for the
activation of p100/RelB complexes and occurs during lymphoid development (63). The
promoter region of human IL-8 gene contains a number of potential binding sites for several
inducible transcription factors including NFκB, activator protein-1 (AP-1), and CAAT/
enhancer-binding protein (C/EBP) (64–66). The expression of IL-8 gene is regulated
primarily at the level of transcription (66, 67). Unlike the AP-1 and C/EBP sites, the NFκB
site is essential for induction and required for maximal gene expression of IL-8 gene (68).
The data from this study shows that NFκB is required for ozone-induced IL-8 production.
First, ozone challenge causes IκBα degradation (NFκB activation). Second, pretreatment of
BEAS-2B cells with the specific NFκB activation inhibitor Bay11-7082 abolishes ozone-
induced IL-8 production. Third, mutation of κB-binding site on the IL-8 promoter causes
significant reduction of IL-8 promoter transcription activity. Moreover, these results also
suggest that ozone exposure induces NFκB activation through the classic pathway since
Bay11-7082, a specific and potent inhibitor of the classic NFκB activation pathway (69),
significantly blocks ozone-induced IL-8 production.
This study further indicates that GSTM1 modulates ozone-induced NFκB activation and
subsequent IL-8 production in BEAS-2B cells through GSH-regulated ROS production
although previous studies on the association of ROS generation with NFκB activation have
produced controversial results (70–75). As described previously, GSTM1 exerts its
antioxidant effect by conjugating reduced GSH with electrophilic ROS. Evidence in support
of ROS-mediated NFκB activation in ozone-exposed cells includes 1.) Observations that
ozone exposure increases ROS production from BEAS-2B cells along with the reduction of
intracellular reduced GST; 2.) Supplementation of antioxidant GSH blocks ozone-induced
IκBα degradation (NFκB activation) and IL-8 production and; 3.) Knockdown of antioxidant
GSTM1 from BEAS-2B cells enhances NFκB activation and IL-8 production. ROS include
superoxide anion, hydroxyl radical, organic peroxide radicals, hydrogen peroxide, and
singlet molecular oxygen (76). They are constantly generated intracellularly in eukaryotic
cells as products of mitochondrial electron transfer chain reactions, and upon exposure to
different environmental stimuli, such as UV light and inflammatory cytokines (77, 78). It
has been speculated that increased ROS production by human bronchial epithelial cells may
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result from increased activity of the microbicidal oxidase, increased mitochondrial activity,
an increased oxidizing environment in the cytoplasm, or a decrease in cellular scavengers of
ROS after ozone treatment (45, 79). As for the mechanisms of ROS-mediated NFκB
activation, previous studies have shown that Syk-mediated phosphorylation of IκBα and p65
(80), and activation of IKK (81) are involved in hydrogen peroxide-induced NFκB
activation. In addition, c-Src has been shown to modulate ROS-induced NFκB activation
(82).
In summary, consistent with our recent in vivo study, this in vitro study using human
bronchial epithelial cells confirms that GSTM1 is a risk factor for ozone-induced
inflammatory responses. Specifically, knockdown of GSTM1 leads to enhanced IL-8
production from human bronchial epithelial cells exposed to ozone, which is verified in
GSTM1-null normal human bronchial epithelial cells. Furthermore, this study demonstrates
that GSTM1 modulation of IL-8 production involves ROS-regulated NFκB activation. Since
the GSTM1 null genotype occurs at high frequency in most ethnic populations (55),
characterization of the GSTM1contribution to air pollution-induced inflammatory lung
diseases and underlying mechanisms provides fundamental information for the design of
preventive and therapeutic measures against air pollutant-related pulmonary disorders.
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GSTM1 glutathione S-transferase mu 1
IL-8 interleukin 8
ROS reactive oxygen species
EGF epidermal growth factor
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GSH-ET glutathione ethyl ester
HRP horseradish peroxidase
KBM keratinocyte basal medium
LDH lactate dehydrogenase
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Figure 1. Ozone exposure increases IL-8 and LDH release from BEAS-2B cells
Confluent BEAS-2B cells grown on 0.4 μm filter supports were exposed to sterile air or 0.4
ppm ozone for 4 h, respectively. IL-8 (A) or LDH (B) levels in the culture medium of the
basolateral compartment were measured. IL-1β (10 ng/ml, 24 h) was used as the positive
control. *, compared to air, P<0.05.
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Figure 2. Ozone-induced ROS production is inhibited by GSH supplementation
A, BEAS-2B cells were pre-incubated with 20 μM carboxy-H2DCFDA for 1 h, prior to
stimulation with 0.4 ppm ozone for 4 h. ROS production was measured with flow cytometry.
B, BEAS-2B cells were pre-incubated with 10 mM glutathione ethyl ester (GSH-ET) for 1
h, prior to stimulation with 0.4 ppm ozone for 4 h. ROS was measured as described
previously. *, compared to air, P<0.05.
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Figure 3. Association of intracellular GSH levels with ozone-induced IL-8 production
A, BEAS-2B cells were exposed to 0.4 ppm ozone for 4 h. Intracellular reduced GSH levels
were measured. B, BEAS-2B cells were pre-incubated with 10 mM glutathione ethyl ester
(GSH-ET) for 1 h, prior to stimulation with 0.4 ppm ozone for 4 h. IL-8 protein levels were
measured using ELISA. *, compared to air, P<0.05.
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Figure 4. GSTM1 modulation of IL-8 production from human bronchial epithelial cells exposed
to ozone
A, BEAS-2B cells were infected with lentiviral scrambled or GSTM1 shRNA particles
(MOI=10) for 24 h, respectively. The cells were lysed and GSTM1 protein levels were
measured using immunoblotting. B, BEAS-2B cells infected with lentiviral scrambled or
GSTM1 shRNA particles were challenged with 0.4 ppm ozone for 4 h. IL-8 protein levels
were measured using ELISA. C, Normal human bronchial epithelial cells from volunteers
with GSTM1-sufficient (GSTM1-WT) or GSTM1-null genotype (n=3 for each genotype)
were assayed for GSTM1 enzymatic activity using immunoprecipitation. D, Normal human
bronchial epithelial cells from human volunteers with GSTM1-sufficient (GSTM1-WT) or
GSTM1-null genotype (n=5 for each genotype) were exposed to 0.4 ppm ozone for 4 h. IL-8
protein levels were measured as described previously. *, compared to air, P<0.05.
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Figure 5. NFκB activation is required for ozone-induced IL-8 production
A, BEAS-2B cells were exposed to 0.4 ppm ozone for 30 min and 60 min. The cells were
then lysed with RIPA buffer. The supernatants of the cell lysates were subjected to
immunoblotting using IκBα antibody. B, BEAS-2B cells were pretreated with 20 μM
Bay11-7082 for 1 h before further stimulated with 0.4 ppm ozone for 4 h. IL-8 protein levels
were measured using ELISA. C, BEAS-2B cells expressing wild-type or κB-binding site
mutated IL-8 promoter-conjugated fLCF, and EGFP constructs were exposed to 0.4 ppm
ozone for 4 h. Levels of fLCF mRNA were measured using RT-PCR and normalized with
EGFP mRNA levels. *, compared to the cells expressing IL-8wt construct exposed to ozone,
P<0.05.
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Figure 6. GSTM1 and GSH modulation of NFκB activation in ozone-treated BEAS-2B cells
A, Infected BEAS-2B cells with lentiviral scrambled or GSTM1 shRNA particles were
challenged with 0.4 ppm ozone for 60 min. The cells were lysed with RIPA buffer and the
supernatants of the cell lysates were subjected to immunoblotting using IκBα antibody. B,
BEAS-2B cells were incubated with 10 mM GSH-ET for 60 min, prior to stimulation with
0.4 ppm ozone for 60 min. IκBα levels in the supernatants of the cell lysates were measured
using immunoblotting.
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